talsaclidine fumarate: Clinical Trials

5 trials of talsaclidine fumarate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 3 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Terminated 2
Phase 31Terminated 1

Follow talsaclidine fumarate: new trials by email Literature Review of talsaclidine fumarate trials Research Report on talsaclidine fumarate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
Talsaclidine, Placebo - Alzheimer Disease
Phase 2TerminatedBoehringer Ingelheim541999-12-012014-09-26
Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers
Propranolol, Talsaclidine - Healthy
Phase 1CompletedBoehringer Ingelheim121999-11-012014-10-15
Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
Talsaclidine - Alzheimer Disease
Phase 2 / Phase 3TerminatedBoehringer Ingelheim1981999-05-012014-09-25
Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers
WAL2014, Placebo - Healthy
Phase 1CompletedBoehringer Ingelheim121999-03-012014-10-15
Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
Talsaclidine, Placebo - Healthy
Phase 1CompletedBoehringer Ingelheim361998-07-012014-10-15

Conditions studied

Alzheimer Disease (2)

Sponsors

Boehringer Ingelheim (5)